Infant with severe penicillamine embryopathy born to a woman with Wilson disease

R Pinter1, W A Hogge, E McPherson

  • 1Department of Genetics, Magee-Women's Hospital, Pittsburgh, Pennsylvania, USA. rpinter@mail.magee.edu

Insights

D-penicillamine (DP) exposure during pregnancy can cause rare congenital abnormalities, including cutis laxa and developmental delays. Prenatal monitoring of maternal copper and zinc may aid management in Wilson disease patients.

Area of Science:

  • Medical Genetics
  • Teratology
  • Pediatric Neurology

Background:

  • Wilson disease (WD) management during pregnancy necessitates careful consideration of medication safety.
  • D-penicillamine (DP) is a chelating agent used for WD, but its teratogenic potential is a concern.

Observation:

  • A case of a male infant born with congenital diffuse cutis laxa, severe micrognathia, limb contractures, and central nervous system abnormalities, including agenesis of the corpus callosum.
  • The infant's mother was treated with D-penicillamine throughout her pregnancy for Wilson disease.

Findings:

  • The infant exhibited a severe phenotype, including chronic lung disease, profound developmental delays, and probable cortical blindness.
  • While the infant's cutis laxa resolved postnatally, the overall outcome was poor.

Implications:

  • This case highlights the potential for D-penicillamine embryopathy, a rare but severe complication.
  • Prenatal assessment of maternal copper and zinc levels may be beneficial for managing pregnant women with Wilson disease on D-penicillamine.
  • Further research is needed to elucidate the exact mechanisms and risk factors associated with D-penicillamine embryopathy.

Related Concept Videos

Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...